Pooler Amy

Pooler Amy is listed in filings as VP at Sangamo Therapeutics, Inc.. This profile follows SEC Form 4 activity through Aug 27, 2024, including 2 public disclosures. Recent filings connect the profile to Sangamo Therapeutics, Inc. (SGMO). The current snapshot covers public activity from Aug 27, 2024. Reported amounts are shown as $424 to $605. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.